Full-Time
Posted on 1/15/2025
Develops specialized language models for healthcare
No salary listed
Senior
Palo Alto, CA, USA
The team is expected to be in the office five days a week in Palo Alto, CA.
Hippocratic AI develops specialized language models designed for healthcare applications. These models are tailored to improve healthcare access, equity, and outcomes by focusing on safety and reliability for non-clinical tasks. The company has created a model that has shown better performance than GPT-4 in numerous healthcare exams, indicating its accuracy. Hippocratic AI serves hospitals, clinics, and healthcare providers, offering AI solutions that enhance patient care and operational efficiency. Unlike general-purpose AI, Hippocratic AI's models are trained on evidence-based healthcare content and validated through a process that includes feedback from healthcare professionals. The company generates revenue by licensing its models to healthcare institutions and forming partnerships, with a commitment to providing safe and effective AI interactions.
Company Size
51-200
Company Stage
Series B
Total Funding
$268.5M
Headquarters
Palo Alto, California
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Flexible Work Hours
In January 2025, global venture investment reached $26 billion, led by healthcare and AI sectors. Hippocratic AI, a California-based healthcare AI developer, raised $141 million. The largest investment was $3 billion in AR startup Infinite Reality. The U.S. dominated with 61% of global investments, while healthcare startups secured $9.4 billion, representing 36% of total investments. AI companies raised $5.7 billion, accounting for 22% of the total.
In his view, Qventus competes with companies like LeanTass, Hippocratic AI and Epic.
Hippocratic AI launches AI agent app store for healthcare.
Alongside the funding news, Hippocratic AI unveiled its AI Agent App Store-a breakthrough platform for clinician-driven healthcare AI development.
Strong customer traction, positive patient response, a recently granted patent, and achieving clinical safety drive company expansion